Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Nivolumab

Stevens-Johnson syndrome: case report

    This is a preview of subscription content, log in to check access.

    Reference

    1. Dasanu CA. Late-onset Stevens-Johnson syndrome due to nivolumab use for hepatocellular carcinoma. Journal of Oncology Pharmacy Practice 25: 2052-2055, No. 8, Dec 2019. Available from: URL: http://doi.org/10.1177/1078155219830166

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Nivolumab. Reactions Weekly 1791, 199 (2020). https://doi.org/10.1007/s40278-020-75044-6

    Download citation